Carcinoma cuniculatum in course of etanercept: Blocking autoimmunity but propagation of carcinogenesis?

International Journal of Immunopathology and Pharmacology

Volumn 27, Issue 2, 2014, Pages 261-266

  Tchernev, Georgi ^a   Guarneri, C ^b   Bevelacqua, V ^c   Wollina, U ^d  

^a UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Apoptosis; ASC TMS1; CARD8; Inflammasome; NLP3; p53; TNF L

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; ETANERCEPT; METHOTREXATE; MINOCYCLINE; PERMANGANATE POTASSIUM; AMOXICILLIN; CLAVULANIC ACID;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNITY; BACTERIAL INFECTION; BIOPSY; CALLUS; CANCER DIAGNOSIS; CARCINOGENESIS; CASE REPORT; CRYOTHERAPY; CURETTAGE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MEDICAL HISTORY; MIDDLE AGED; PATIENT REFERRAL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; THERMOCOAGULATION; TREATMENT DURATION; VERRUCA VULGARIS; VERRUCOUS CARCINOMA; WALKING DIFFICULTY; WEDGE BIOPSY; WIDE EXCISION; APOPTOSIS; CELL INFILTRATION; CELL PROLIFERATION; DACTYLITIS; DISEASE DURATION; FULL THICKNESS SKIN GRAFT; KNEE ARTHRITIS; LOW BACK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; SKIN BIOPSY; SKIN CARCINOGENESIS; SPINDLE CELL;

ANTI-INFLAMMATORY AGENTS; APOPTOSIS; ARTHRITIS, PSORIATIC; AUTOIMMUNITY; BIOPSY; CARCINOMA, VERRUCOUS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; IMMUNOGLOBULIN G; INFLAMMASOMES; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN NEOPLASMS;

EID: 84907311608     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201402700213     Document Type: Article

References (29)

1. Müller-Ladner U, Alten R, Heiligenhaus A, et al. "TRECID", TNFalpha related chronic inflammatory diseases - a new multiple diseases bridging concept. Dtsch Med Wochenschr 2009; 134(42):2132-6.
2. Mathews RJ, Robinson JI, Battellino M, et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 2013; 73(6):1202-10.
3. Tchemev G, Wollina U. Pathways of tumor development and progression in drug-induced nonmelanoma skin cancer: a new hope or the next great confusion? Wien Med Wochenschr 2014. [Epub ahead of print].
4. Yang CA, Huang ST, Chiang BL. Association of NLRP3 and CARD8 genetic polymorphisms with juvenile idiopathic arthritis in a Taiwanese population. Scand J Rheumatol 2013; 43(2):146-52.
5. Salminen A, Kauppinen A, Hiltunen M, Kaarniranta K. Epigenetic regulation of ASC/TSM1 expression: potential role in apoptosis and inflammasome function. Cell Moll Life Sci 2013; 71(10):1855-64.
6. Borrás-Blasco J, Gracia-Pérez A, Rosique-Robles JD, Casterá ME, Abad FJ. Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients. Expert Opin Biol Ther 2014; 14(2):145-50.
7. Tatarkova I, Cetkovska P. Deep vein thrombosis and lung cancer in a patient with psoriasis under anti-tumor necrosis factor treatment: a case study. Dermatol Ther 2013. doi: 10.1111/dth.12041. [Epub ahead of print].
8. Miranda LQ, Bressan AL, Rehfeldt FV, Vasconcelos BN, Gripp AC. Psoriasis, lymphoma and etanercept: is there a correlation? An Bras Dermatol 2012; 87(1):139-41.
9. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948; 23:670-8.
10. Aird I, Johnson D, Lennox B, Stanfield AG. Epithelioma cuniculatum. A variety of squamous carcinoma peculiar to the foot. Br J Surg 1954; 42:245-50.
11. Jain A, Singh JA. Harms of TNF inhibitors in rheumatic diseases: a focused review of the literature. Immunotherapy 2013; 5:265-99.
12. De Simone C, Amerio P, Amoruso G, et al. Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue? Expert Opin Biol Ther 2013; 13(12):1673-82.
13. Rodust PM, Stockfleth E, Ulrich C, Leverkus M, Eberle J. UV-induced squamous cell carcinoma - a role for antiapoptotic signalling pathways. Am J Dermatopathol 2014; (Epub ahead of print).
14. Omran OM, Ata HS. Expression of tumor necrosis factor-related apoptosis-inducing ligand death receptors DR4 and DR5 in human nonmelanoma skin cancer. Environ Toxicol 2012; 27:433-44.
15. Morales-Lara MJ, Cañete JD, Torres-Moreno D, Hernández MV, Pedrero F, Celis R, Garcia-Simón MS, Conesa-Zamora P. Effects of polymorphisms in TRAILR1 and TRAILR1A on the responce to anti TNF therapies with rheumatoid and psoriatic arthritis. Joint Bone Spine 2012; 79:591-96.
16. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Ann Rev Immunol 2011; 29:707-35.
17. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-32.
18. Lamkanfi M, Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 2009; 227: 95-105.
19. Martinon F, Mayor A, Tschopp J. The inflammasomes: guardians of the body. Annu Rev Immunol 2009; 27:229-65.
20. Hasegawa M, Kawase K, Inohara N, Imamura R, Yeh WC, Kinoshita T, Suda T. Mechanism of ASC mediated apoptosis: bid dependent apoptosis in type II cells. Oncogene 2007; 26:1748-56. (Pubitemid 46426195)
21. Kantari C, Walczak H. Caspase-8 and bid: caught in the act between death receptors and mitochondria. Biochim Biophys Acta 2011; 1813:558-63.
22. Sisto M, D' Amore M, Caprio S, Mitolo V, Scagliusi P, Lisi S. Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands. Ann NY Acad Sci 2009; 1171:407-14.
23. Tchemev G, Cardoso JC, Arseniev L, Okamoto H. Extrinsic apoptotic pathways: a new potential "target" for more sufficient therapy in a case of cutaneous anaplastic large cd30+ alk-T-cell lymphoma. Indian J Dermatol 2011; 56(1):87-91.
24. Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST, Vertino PM. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation induced gene silencing in human breast cancers. Cancer Res 2000; 60:6236-42.
25. Virmani A, Rathi A, Sugio K, et al. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer. Int J Cancer 2003; 106:198-204. (Pubitemid 36835171)
26. Guan X, Sagara J, Yokoyama T, Koganehira Y, Oguchi M, Saida T, Taniguchi S. ASC/TSM1, a caspase -1 activating adaptor, is downregulated by abrerrant methylation in human melanoma. Int J Cancer 2003; 107:202-208. (Pubitemid 37152898)
27. Levine JJ, Stimson-Crider KM, Vertino PM. Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 2003; 22:3475-88. (Pubitemid 36713746)
28. Tchemev G. Sexually transmitted papillomavirus infections: epidemiology pathogenesis, clinic, morphology, important differential diagnostic aspects, current diagnostic and treatment options. An Bras Dermatol 2009; 84(4):377-89.
29. Guarneri C, Bevelacqua V, Semkova K, Tchernev G, Tempel S, Wollina U. Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges. Wien Med Wochenschr 2013; 163(15-16):368-71.